Research by aesthetic manufacturer Teoxane highlights growing concern around facial fat loss. Conducted by independent European data collector Norstat on behalf of Teoxane, the research surveyed 2,500 UK participants. A
The Advertising Standards Authority (ASA) has published new research into how patients interpret weight-loss treatment advertisements. The findings show that, out of 2,030 participants, most believe weight-loss treatment advertisements can
Skeletal muscle is a dynamic, metabolically active organ essential for maintaining health throughout the lifespan. Beyond providing strength and locomotion, muscle regulates glucose metabolism, supports immune signalling and contributes to
The Advertising Standards Authority (ASA) has banned a series of social media advertisements promoting prescription-only weight-loss medicines (POMs) through affiliate and referral links. The organisation notes that these rulings mark
Dr Ahmed El Muntasar presents an overview of strategies for addressing post-weight loss skin changes Significant weight loss, whether achieved through lifestyle modification, bariatric surgery or pharmacological interventions such as
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved a new maximum weekly dose of semaglutide of up to 7.2mg. The regulatory agency shares that this is designed to
Three practitioners discuss the pathophysiology of skin laxity and evaluate treatment modalities aimed at optimising both aesthetic appearance and functional outcomes Weight loss can result from a variety of interventions.
Aesthetics investigates the risks and repercussions of inappropriate weight-loss prescribing An ITV News investigation has revealed that young people with a healthy body mass index (BMI) are using artificial intelligence
A review published in the British Medical Journal indicates that individuals using weight-loss medication may regain lost weight up to four times faster than those who lose weight through conventional
The US Food and Drug Administration (FDA) has approved weight-loss drug Wegovy as the first once-daily oral GLP-1 weight-loss pill. The FDA approved the first oral GLP‑1 medication for chronic
